This information was published on 2024-04-16T00:04:29 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2405656 |
| (220) |
15 Nov 2023
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure. |
| (540) | UPSTELDA |
| (550) | Word |
| (730) |
Amgen Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.